This week’s issue covers developments shaping access to HIV prevention and the future of US biomedical research, including new pathways to accelerate access to lenacapavir for HIV PrEP, calls for ...

The US National Institutes of Health (NIH) signs a 10-year agreement that could move significant NIAID research funding to the Department of Defense, as NIAID separately proposes a major restructuring ...

Alimatravir (AMI) is an investigational monthly pill for HIV prevention developed by Merck/MSD. AMI is currently in phase 3 efficacy trials: EXPrESSIVE-10 and EXPrESSIVE-11. EXPrESSIVE-10 launched in ...

The Impact Report AVAC’s series celebratingcritical wins. The Impact Report highlights the power of advocacy, research translation, and partnership to advance HIV prevention and global health equity.

We’ve lost another champion for global health and reproductive rights this week: Gloria Steinem, the pioneering feminist and activist who spent decades fighting for gender equality, reproductive ...

Scientific consensus is evolving, but PrEP clinical equity remains unachieved. Recent data has challenged the “conventional wisdom” surrounding vaginal PrEP tissue concentrations, proving oral PrEP ...

In support of Dr. Anthony Fauci, AVAC submitted a letter to the Committee on Homeland Security and Governmental Affairs ahead of a Congressional hearing focused on the origins of COVID-19. This letter ...

New York City, September 12, 2024 – AVAC welcomes the groundbreaking results of the PURPOSE 2 HIV prevention study of twice-yearly injectable lenacapavir for PrEP among 3,200 cisgender men, ...

The Civil Society Caucus of the Coalition to Accelerate Access to Long-Acting HIV PrEP developed a new resource that offers practical guidance to help civil society, advocates and implementers ...

The call to collective responsibility followed presentation of CROI’s inaugural Lifetime Achievement Award to former Director of the National Institute of Allergy and Infectious Diseases (NIAID) Carl ...

Pandemic treaty negotiations ahead of the World Health Assembly in May show rising tensions, as countries push for equity in pathogen sharing, alongside the expansion of US bilateral health deals and ...